Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Re...
^
Original-Research: Northwest Biotherapeutics Inc. - from First Berlin Equity
Research GmbH
28.05.2026 / 13:43 CET/CEST
Dissemination of a Research,…
0,201€
11,05%
Echtzeit-Aktienkurs Northwest Biotherapeutics Inc.
Bid:
Ask:
Nachrichten zur Northwest Biotherapeutics Inc. Aktie
Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Re...
^Original-Research: Northwest Biotherapeutics Inc. - from First Berlin EquityResearch GmbH28.05.2026 / 13:43 CET/CESTDissemination of a Research, transmitted by EQS News…
Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Re...
^
Original-Research: Northwest Biotherapeutics Inc. - from First Berlin Equity
Research GmbH
24.03.2026 / 16:01 CET/CEST
Dissemination of a Research,…
Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Re...
^Original-Research: Northwest Biotherapeutics Inc. - from First Berlin EquityResearch GmbH24.03.2026 / 16:01 CET/CESTDissemination of a Research, transmitted by EQS News…
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH):...
^
Original-Research: Jaguar Health Inc - from First Berlin Equity Research
GmbH
24.03.2026 / 14:39 CET/CEST
Dissemination of a Research,…
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant
SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company…
Northwest Biotherapeutics: All Is Not Well With This One
…